Compound C enhances the anticancer effect of aspirin in HER-2-positive breast cancer by regulating lipid metabolism in an AMPK-independent pathway

Various clinical studies have determined that aspirin shows anticancer effects in many human malignant cancers, including human epidermal growth factor receptor-2 (HER-2)-positive breast cancer. However, the anti-tumor mechanism of aspirin has not been fully defined. The aim of this study was to det...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ying, Yan, Bohua, Xu, Wenqin, Guo, Lili, Wang, Zhe, Li, Guoyin, Hou, Niuniu, Zhang, Jian, Ling, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990926/
https://www.ncbi.nlm.nih.gov/pubmed/32025207
http://dx.doi.org/10.7150/ijbs.39936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990926/
https://www.ncbi.nlm.nih.gov/pubmed/32025207
http://dx.doi.org/10.7150/ijbs.39936

Ejemplares similares